SH3BP2
protein-codingSH3 domain binding protein 2, the group of Pleckstrin homology domain containing|SH2 domain containing
Gene summary
The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~48.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007315
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007315
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007315
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007315
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: As bone lesions are typically self-limiting, surgical interventions treatment may not be necessary (with the exception of aggressive lesions resulting in severe functional issues, or for aesthetic reasons)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SH3BP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001122681.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 166 | 3 | 173 | ||
| missense | 5 | 6 | 332 | 50 | 1 | 394 |
| nonsense | 6 | 1 | 7 | |||
| start loss | 1 | 1 | ||||
| frameshift | 18 | 18 | ||||
| splice donor/acceptor (+/-2bp) | 8 | 1 | 9 | |||
| Total | 5 | 6 | 369 | 218 | 4 | 602 |
Highest pathogenic variant AF is 0.0000014009802
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001116153.1 | 12 | MANE Select | |
| Ensembl | ENSP00000422168.3 | 12 | MANE Select | |
| RefSeq | NP_001139327.1 | 13 | Standard | |
| RefSeq | NP_001139328.1 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Natural killer cell mediated cytotoxicity - Homo sapiens (human)
- B Cell Receptor Signaling Pathway
- TCR
- BCR
- TCR signaling in naï
Biological Process
- signal transduction
- positive regulation of signal transduction
Molecular Function
- phosphotyrosine residue binding
- SH3/SH2 adaptor activity
- protein binding
- SH3 domain binding
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000503393
- Coding exons
- 13
- Length
- 48076
- Individuals with no LoFs
- 125638
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 110
- Defined
- 125748
- p
- 0.000437
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.292 | 344 | 360 | 0.957 | 0.0000236 | 3972 |
| Missense (PolyPhen) | 97 | 105.97 | 0.91532 | 1087 | ||
| Synonymous | -1.45 | 179 | 156 | 1.15 | 0.0000115 | 1287 |
| Loss of Function | 1.02 | 20 | 25.6 | 0.781 | 0.00000136 | 303 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.0016 | 0.00074 | notable |
| European (Non-Finnish) | 0.00066 | 0.00062 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binds differentially to the SH3 domains of certain proteins of signal transduction pathways. Binds to phosphatidylinositols; linking the hemopoietic tyrosine kinase fes to the cytoplasmic membrane in a phosphorylation dependent mechanism.;
- Disease
- DISEASE: Cherubism (CRBM) [MIM:118400]: An autosomal dominant syndrome characterized by excessive bone degradation of the upper and lower jaws, which often begins around three years of age. It is followed by development of fibrous tissue masses, which causes a characteristic facial swelling. {ECO:0000269|PubMed:11381256, ECO:0000269|PubMed:12900899, ECO:0000269|PubMed:14577811}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.151
Intolerance Scores
- LoFtool
- 0.0376
- RVIS EVS
- -0.84
- RVIS percentile EVS
- 11.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.760
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |